MiRNA-based therapy for Hepatocelluar Carcinoma: MiRNA-101 inhibits liver cancer via down regulation of Lin28 and Igf2bp3, 1/September/2014, 08.23 am

Androgen therapy for Myocardial disorders: Androgens improve myocardial function and inhibit myocardial infarction via up regulation of their target genes, 1/September/2014, 06.45 am
September 1, 2014
Insights into the regulation of Lipid metabolism: NOD2/CARD15 inhibits Lipoprotein Lipase via up regulation of its target gene, 2/September/2014, 05.30 am
September 2, 2014
Show all

A recent study from the Children’s Research Institute, Departments of Pediatrics and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA  shows that Lin28b Is Sufficient to Drive Liver Cancer and Necessary for Its Maintenance in Murine Models.”  This study was published in the August 11 2014 Cancer Cell (No.1 journal in basic cancer biology with an I.F of ~27.238)  by Prof Zhu H, Nguyen LHand others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports that:  MiRNA-based therapy for Hepatocelluar Carcinoma:  MiRNA-101 inhibits liver cancer via down regulation of Lin28 and Igf2bp3. MiRNA-101, by decreasing the expression of its target gene, it may decrease tumor burden and prolong survival. Together, this study suggests that pharmacological formulations encompassing “MiRNA-101 or its activators” may be used to inhibit hepatocellular carcinoma.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based therapy for Hepatocelluar Carcinoma:  MiRNA-101 inhibits liver cancer via down regulation of Lin28 and Igf2bp3,  1/September/2014,  08.23 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.